Potential risks include: Infection risk if injections are administered in non-clinical settings without appropriate sterile technique Allergic reactions to any component of the formulation Liver toxicity theoretical concern with excessive methionine or choline Drug interactions particularly if combined with other supplements or medications Unknown long-term effects due to absence of longitudinal safety data The MHRA advises caution with unlicensed injectable products, as quality, purity, and sterility cannot be guaranteed
The foundation for visible improvement is being established even when the mirror does not yet reflect it
**Never shake.** Shaking denatures peptide bonds and can reduce potency
In some cases, healthcare providers may adjust the frequency, for example, some patients might be advised to take the injection twice weekly or once every two weeks, depending on their specific goals and how they respond to treatment
Derivatives of molecular oxygen that lead to molecular damage (for example, hydrogen peroxide (H 2 O 2 ) and superoxide anion radical (O 2 ))